Idea principal
A systematic review of 89 publications, selected from 8073 studies, found that sleep disturbances and disorders in people with cancer were reported at prevalences of up to 95%, with insomnia and obstructive sleep apnea syndrome (OSAS) especially common. The upper figure is a maximum across very different studies, so it is not a typical rate for any one group.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Sleep disorders, especially insomnia, are common across cancer types, but how often they occur is poorly known, and causes include earlier sleep problems, psychological distress and cancer treatment side effects. The authors reviewed the literature on sleep and sleep disorders in people with cancer to map what is known.
Población y método
Systematic literature review. Of 8073 studies identified through PubMed, PsycInfo and Web of Knowledge, 89 publications qualified for analysis: 26 on sleep and fatigue in cancer and 61 on sleep disorders in cancer. The abstract does not describe how the studies were assessed or combined, and no meta-analysis is reported.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Prevalence of sleep disturbances and/or sleep disorders in people with cancer was reported at up to 95%.
- 2Sleep disturbances and disorders in cancer, including insomnia, OSAS, narcolepsy, restless legs syndrome (RLS) and REM sleep behavior disorder, can be associated with several conditions.
- 3Insomnia and OSAS were the most common problems among them.
- 4Cancer treatment side effects and cancer-related psychological dysfunction can be triggered or worsened by sleep disturbance, according to the authors.
Límites e incertidumbre
- 1'Up to 95%' is the top of a range across studies, and the abstract gives no pooled or typical prevalence, so it cannot be used as an average.
- 2No pooled analysis is reported, so differences by cancer type, treatment stage and way of measuring sleep are not reflected in the numbers.
- 3Because the review is built on observational reports, the direction of cause between poor sleep, treatment effects and distress cannot be separated.
- 4The abstract does not state study quality or sample sizes. This reading is based on the abstract only.
Relevancia práctica
If you or someone close to you has cancer and sleeps badly, you are in very large company, and poor sleep is something worth raising with the oncology team instead of treating as inevitable. The review calls for evidence-based treatment of sleep problems alongside other physical and mental health needs. It does not say which treatment to use, and decisions belong with your clinician.
Tus datos
A wearable can show total sleep time, awakenings and consistency, which is useful to bring to an appointment. Sleep stage estimates and apnea signals from consumer devices are not diagnostic, so use the same device and look at weeks of patterns rather than a single night.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Introduction
Sleep disorders, especially insomnia, are very common in different kinds of cancers, but their prevalence and incidence are not well-known. Disturbed sleep in cancer is caused by different reasons and usually appears as a comorbid disorder to different somatic and psychiatric diagnoses, psychological disturbances and treatment methods. There can be many different predictors for sleep disturbances in these vulnerable groups, such as pre-existing sleep disorders, caused by the mental status in cancer or as side effect of the cancer treatment.
Methods
A systematic literature review of 8073 studies was conducted on the topic of sleep and sleep disorders in cancer patients. The articles were identified though PubMed, PsycInfo and Web of Knowledge, and a total number of 89 publications were qualified for analysis.
Results
The identified eighty-nine studies were analyzed on the topic of sleep and sleep disorders in cancer, twenty-six studies on sleep and fatigue in cancer and sixty-one studies on the topic of sleep disorders in cancer. The prevalence of sleep disturbences and/or sleep disorders in cancer was up to 95%.
Discussion
Sleep disturbances and sleep disorders (such as insomnia, OSAS, narcolepsy and RLS; REM-SBD) in cancer patients can be associated with different conditions. Side effects of cancer treatment and cancer-related psychological dysfunctions can be instigated by sleep disturbances and sleep disorders in these patients, especially insomnia and OSAS are common. An evidence-based treatment is necessary for concomitant mental and/or physical states.
Fuentes y atribución
Sleep Disorders in Cancer-A Systematic Review.
Büttner-Teleagă A, Kim YT, Osel T, Richter K.
International journal of environmental research and public health · 2021-11-07
DOI: 10.3390/ijerph182111696 ↗PubMed · 34770209 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

